Pfizer Symposium

Professor Daniel Nomura, University of California, Berkeley. "Reimagining Druggability Using Chemoproteomic Platforms." Dr. David Edmonds, Pfizer, Inc.: "Discovery of PF-06882961: A potent, orally bioavailable small molecule agonist of the GLP-1 Receptor...

Professor Craig Crews, Yale University. Dr. Martin Edwards, Pfizer, Inc.

Professor Dustin Maly, University of Washington, Seattle."Engineered Protein Switches for Studying Dynamic Cellular Processes." Dr. Martin Pettersson, Research Scientist, Pfizer Inc., "Discovery of clinical candidate PF-06648671: a potent, highly brain...

Professor Timothy F. Jamison, Massachusetts Institute of Technology. "Synthesis Design Through the Lens Flow of Chemistry." Dr. Katherine Lee, Research Scientist, Pfizer, Inc. "The Discovery of an IRAK4 Clinical Candidate from Fragment-Based Drug Design."

Dr. Chakrapani Subramanyam, Pfizer, Inc. " Applying Medicinal Chemistry Principles to the Discovery of Linkers, Payloads and Antibody Drug Conjugates for the Treatment of Cancer." Professor Jin-Quan Yu, The Scripps Research Institute. " Ligand-Accelerated...

Pfizer Symposium. Professor Scott Denmark, University of Illinois. Lewis Base Activation of Lewis Acids: An Evolving Paradigm for Catalysis in Main Group Chemistry. Dr. Chris O'Donnell, Pfizer. Applying Medicinal Chemistry Principles to the Discovery of...